On the prohibition of conflicts of interest in pharmaceutical regulation: Precautionary limits and permissive challenges. A commentary on Sismondo (66:9, 2008, 1909¿14) and O'Donovan and Lexchin
journal contribution
posted on 2023-06-07, 20:06authored byJohn Abraham